VC firms
BioVeda China Fund (BVCF) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, and Bejing
Overview
Employees
11-50
Investment Type
Venture Capital
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Persons 3
| Date | First Name | Last Name | Title | Location | |||
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Bing | Zhuo | Adviser | |||||
| Yunlong | Huang | Adviser |
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 14, 2026 | Drug Farm Raises $55M in First Close of Series D Funding | Drug Farm, a NYC- and Shanghai, China-based biotechnology company developing novel drug targets, raised $55M in first close of its Series D financing. The round was Shanghai Pudong Leading Area Investment Center and Shanghai Puxing Collabor... |
| Jan 31, 2025 | Houston's Biotech Revolution: A New Dawn in Cancer Treatment | In the heart of Houston, a biotech revolution is brewing. Cellenkos Therapeutics, a female-founded company, is making waves with its innovative approach to treating myelofibrosis, a rare and challenging blood cancer. This breakthrough could... |
| Jan 29, 2025 | Play it back: Houston home tech startup begins 2025 with fresh funding | One of the dozen or so Houston startups kicking of the new year with fresh funding is SmartAC.com, a company that's designed a platform that enables contractors in the HVAC and plumbing industries to monitor, manage, and optimize their main... |
| May 7, 2021 | Oculis closes US$57 million Series C financing | The oversubscribed round was co-led by new investors BVCF Management and Hyfinity Investments, with VI Partners and Wille AG joining the company’s existing investors, Bay City Capital, Brunnur Ventures, EarlyBird, funds managed by Tekla Cap... |
| May 7, 2021 | Oculis closes US$57 million Series C financing | |
| Apr 18, 2016 | Lifescience-focussed BioVeda China Fund seeks $400m for fourth vehicle | Premium China-based investment firm with a focus on life sciences BioVeda China Fund (BVCF) is working on launching a $400 million fund, according to China Money Network quoting unnamed sources. Continue reading this story with a subscripti... |
| Jan 9, 2015 | DiaCarta Raises $8M in Series A Financing | DiaCarta, Inc., a Hayward, CA-based biotechnology company, raised $8m in Series A financing. Shanghai-based BioVeda China Fund made the investment. The company intends to use the funds to expand its product portfolio and support global comm... |
| Feb 6, 2014 | Jaguar Animal Health Raises $2M | Jaguar Animal Health, Inc., a San Francisco, CA-based company focused on the development and commercialization of health solutions for the global veterinary marketplace from plants used traditionally in rain forest areas, raised $2m in a Se... |
| Aug 22, 2013 | MicuRx Pharmaceuticals Raises $25M in Series B Financing | MicuRx Pharmaceuticals, Inc., a Hayward, CA-based biopharmaceutical company developing innovative antibiotics, raised $25m in Series B financing. The round was led by BVCF, with participation from existing investors Morningside Group and De... |
Reviews 0
FAQ about BVCF
How many startups has BVCF invested in?
BVCF has 1 portfolio company on Parsers VC.
What has the press written about BVCF?
Parsers VC has collected 10 articles mentioning BVCF, among them “Drug Farm Raises $55M in First Close of Series D Funding” (Jul 14, 2026) and “Houston's Biotech Revolution: A New Dawn in Cancer Treatment” (Jan 31, 2025).
Is BVCF still active?
Yes, BVCF is active; its latest activity on Parsers VC dates from Jul 14, 2026.